David Shapiro
2017
In 2017, David Shapiro earned a total compensation of $2M as Chief Medical Officer at Intercept Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,255 |
|---|---|
| Option Awards | $645,889 |
| Salary | $489,300 |
| Stock Awards | $643,080 |
| Other | $30,330 |
| Total | $1,979,854 |
Shapiro received $645.9K in option awards, accounting for 33% of the total pay in 2017.
Shapiro also received $171.3K in non-equity incentive plan, $489.3K in salary, $643.1K in stock awards and $30.3K in other compensation.
Rankings
In 2017, David Shapiro's compensation ranked 5,543rd out of 14,666 executives tracked by ExecPay. In other words, Shapiro earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,543 out of 14,666 | 62nd |
Division Manufacturing | 2,001 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 611 out of 2,075 | 71st |
Industry group Drugs | 470 out of 1,731 | 73rd |
Industry Pharmaceutical Preparations | 367 out of 1,333 | 73rd |
Source: SEC filing on April 27, 2018.
Shapiro's colleagues
We found four more compensation records of executives who worked with David Shapiro at Intercept Pharmaceuticals in 2017.